For example, purinergic receptors, especially P2X7 and P2Y12, regulate microglial activation and mediate neurotoxicity, and similarly, pharmacological inhibition of P2X7 and P2Y12 reduces brain damage in experimental stroke models (80). This evidence concerns the gene P2RY12 and Stroke.